Pricing Log in Create free account

Climb Bio, Inc. (CLYM) vs WAVE Life Sciences Ltd. (WVE)

Climb Bio, Inc. and WAVE Life Sciences Ltd. are both Biotechnology companies. Climb Bio, Inc. and WAVE Life Sciences Ltd. are of similar size ($628.6M and $626.6M). Climb Bio, Inc. has the higher net margin (0.00% vs −309.7%) and the lower return on invested capital (−71.7% vs 0.00%). Across the 12 metrics below, Climb Bio, Inc. leads on 10 and WAVE Life Sciences Ltd. on 2.

Valuation

Metric CLYM WVE Biotechnology median
P/E n/m n/m 8.50
P/S n/m 9.74 9.71
P/B 3.12 1.40 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 2.23 9.21
Earnings yield (8.45%) (34.94%) (33.15%)
Free cash flow yield (7.11%) (30.34%) (25.50%)

Profitability

Metric CLYM WVE Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (333.36%) 0.00%
Net margin 0.00% (309.73%) 0.00%
Free cash flow margin 0.00% (295.46%) 0.00%
Return on equity (27.10%) (68.31%) (56.36%)
Return on assets (26.27%) (49.95%) (48.04%)
Return on invested capital (71.73%) 0.00% 0.00%

Growth

Metric CLYM WVE Biotechnology median
Revenue growth (TTM) — (30.42%) 6.02%
EPS growth (last fiscal year) 42.48% (72.86%) 30.26%
Revenue growth, 5-year CAGR — 16.31% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CLYM WVE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 31.45 9.99 4.72
Net debt to EBITDA 1.44 2.92 0.96

Dividend

Metric CLYM WVE Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CLYM WVE Biotechnology median
Market cap 626.63m 628.58m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack